[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360843-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360843-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dna-hypomethylation-in-pancreatic-cancer-tissues-before-treatment-defined-by-kras-mutated-circulating-tumor-dna-associated-with-poor-prognosis","DNA Hypomethylation in Pancreatic Cancer Tissues Before Treatment, Defined by KRAS-mutated Circulating Tumor DNA - Associated With Poor Prognosis","","Objective: Aberrant hypomethylation of LINE-1 and SATa in pancreatic cancer cells increases malignant potential, and circulating tumor DNA (ctDNA) may relate to micrometastasis and appear more often in advanced PDAC. Methods: Thirty-seven PDAC patients treated in 2014–2017 were studied; LINE-1 and SATa relative demethylation levels were quantified by methylation-specific qPCR, and KRAS-mutated ctDNA was monitored by droplet digital PCR. Results: SATa hypomethylation after treatment associated with poor prognosis; LINE-1 did not. Conclusions: Combining pretreatment tumor DNA hypomethylation with KRAS-mutated ctDNA status after surgery or starting first-line chemotherapy links to poor outcomes in PDAC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dna-hypomethylation-in-pancreatic-cancer-tissues-before-treatment-defined-by-kras-mutated-circulating-tumor-dna-associated-with-poor-prognosis/360843/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dna-hypomethylation-in-pancreatic-cancer-tissues-before-treatment-defined-by-kras-mutated-circulating-tumor-dna-associated-with-poor-prognosis/360843.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of evaluating LINE-1 and SATa in pancreatic cancer?","Question",{"text":63,"@type":64},"The study aimed to clarify how aberrant hypomethylation of LINE-1 and SATa, together with KRAS-mutated ctDNA status, relates to pancreatic cancer outcomes and prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were relative demethylation levels and KRAS-mutated ctDNA measured?",{"text":68,"@type":64},"Relative demethylation levels of LINE-1 and SATa were calculated from extracted DNA using methylation-specific quantitative PCR, and KRAS-mutated ctDNA was monitored using droplet digital PCR.",{"name":70,"@type":61,"acceptedAnswer":71},"Which DNA hypomethylation marker showed a significant association with poor prognosis?",{"text":72,"@type":64},"SATa relative demethylation after treatment (based on ctDNA status) showed a significant association with poor prognosis, while LINE-1 cut-offs and SATa before treatment did not.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360843,1790194012,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","ORIGINAL ARTICLE  \nDNA Hypomethylation in Pancreatic Cancer Tissues Before Treatment, Defined by KRAS-mutated Circulating Tumor DNA, is Associated With Poor Prognosis  \nFumiaki Watanabe, MD, PhD, Koichi Suzuki, MD, PhD, Ryuji Hasebe, MD, Yuki Mizusawa, MD, Hidetoshi Aizawa, MD, Iku Abe, MD, PhD, Yuhei Endo, MD, PhD, Kosuke Ichida, MD, PhD, Koetsu Inoue, MD, PhD, Hiroshi Noda, MD, PhD, and Toshiki Rikiyama, MD, PhD  \nObjectives: Aberrant hypomethylation of long interspersed nucleotide element-1 (LINE-1) and satellite alpha (SATa) in pancreatic cancer cells increases malignant potential. In addition, circulating tumor DNA (ctDNA) is likely to be associated with micrometastasis and appears more frequently in advanced pancreatic ductal adenocarcinoma (PDAC) patients. In this study, we elucidated the relationship between these factors.  \nMaterials and Methods: A total of 37 patients with PDAC who underwent surgery or first-line chemotherapy were selected in 2014- 2017. DNA extracted from surgical or biopsy specimens was used to calculate the relative demethylation levels (RDLs) of the LINE-1 and SATa using methylation-specific quantitative PCR. KRAS--mutated ctDNA was monitored using droplet digital PCR. Receiver operating characteristic curve analysis was performed to determine the cut-off values of LINE-1 and SATa RDLs before and after surgery or during first-line chemotherapy based on ctDNA status (presence or absence) .  \nResults: Median LINE-1 RDL before treatment was higher inpatients with ctDNA than in those without, but these cut-off values (LINE-1 ≥ 0.058 and 0.055) peritreatments did not link to prognosis (P = 0.762 and 0 .933) . Conversely, the cut-off value of SATa RDL (SATa ≥ 0. 150) based on ctDNA status after treatments showed a significant association with poor prognosis (P = 0.038) . On the other hand, the cut-off value of SATa RDL (SATa ≥ 0. 155) before treatment was found to have no association with prognosis (P = 0.408) .  \nReceived for publication January 28, 2025; accepted January 15, 2026.  \nFrom the Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan.  \nThis study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (grant numbers JP 16K10514 and 24K10432) and by the JKA Foundation through its promotion funds from the Keirin Race  \n(grant number 27-1-068 (2)) . The authors declare no conflict of interest.  \nAddress correspondence to: Fumiaki Watanabe, MD, Department of Surgery, Saitama Medical Center, Jichi Medical University, 1-847, Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan (email: [fwatanabe@jichi.ac.jp](fwatanabe@jichi.ac.jp)) .  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, [www.pancreasjournal.com](www.pancreasjournal.com).  \nCopyright © 2026 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nDOI: 10. 1097/MPA.0000000000002650  \nConclusions: Evaluating pretreatment tumor DNA hypomethylation together with KRAS-mutated ctDNA status after surgery or initiation of first-line chemotherapy is associated with poor prognosis in PDAC.  \nKey Words: pancreatic ductal adenocarcinoma, circulating tumor DNA, KRAS, hypomethylation, long interspersed nucleotide element 1, satellite alpha  \n(Pancreas 2026;55:e747–e757)  \nEpigenetic abnormalities include oncogenic alterations in  \nthe epigenetic code, which are involved in cancer development and progression. 1,2 Among these, promoter DNA methylation is a major alteration that silences tumorsuppressor genes","cbCaiaKPVKJASX2C","https://ap.wps.com/l/cbCaiaKPVKJASX2C","pdf",1283412,11,"English","# Objectives\n# Materials and Methods\n## Patient cohort and sampling\n## Methylation and ctDNA measurement\n## ROC-based cut-off determination\n# Results\n## LINE-1 demethylation and prognosis\n## SATa demethylation after vs before treatment\n# Conclusions\n# Background and context on epigenetic changes","[{\"question\":\"What was the main objective of evaluating LINE-1 and SATa in pancreatic cancer?\",\"answer\":\"The study aimed to clarify how aberrant hypomethylation of LINE-1 and SATa, together with KRAS-mutated ctDNA status, relates to pancreatic cancer outcomes and prognosis.\"},{\"question\":\"How were relative demethylation levels and KRAS-mutated ctDNA measured?\",\"answer\":\"Relative demethylation levels of LINE-1 and SATa were calculated from extracted DNA using methylation-specific quantitative PCR, and KRAS-mutated ctDNA was monitored using droplet digital PCR.\"},{\"question\":\"Which DNA hypomethylation marker showed a significant association with poor prognosis?\",\"answer\":\"SATa relative demethylation after treatment (based on ctDNA status) showed a significant association with poor prognosis, while LINE-1 cut-offs and SATa before treatment did not.\"}]","DNA Hypomethylation in Pancreatic Cancer Tissues Before Treatment, Defined by KRAS-mutated Circulating Tumor DNA - Associated With Poor Prognosis | PDF",1790141785,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b167ea8160faa55f6cdc27a857f6de2e.webp",983,1363,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a275ed39f1eb7a40cc91d306c3c0b20.webp",982,1362,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a15fb19cd426c17f119316a9fc03ba66.webp",981,1361,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce24ec1ad3d314a36ecbcbc6b5f722fa.webp",980,1359]